Home LiteratureArticle Details
PMID: 17050592 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.

Journal of virology ·Vol. 81 ·No. 1 ·2007-01-00 ·Pages 125-40

Lambelé M, Labrosse B, Roch E, Moreau A, Verrier B, Barin F, Roingeard P, Mammano F, Brand D

Abstract

The motifs involved in the various functions of the human immunodeficiency virus type 1 (HIV-1) gp41 cytoplasmic tail (CT), particularly those related to the intracellular trafficking and assembly of envelope glycoproteins (Env) onto core particles, have generally been assessed with a restricted panel of T-cell laboratory-adapted virus strains. Here, we investigated gp41 CT sequences derived from individuals infected with HIV-1 viruses of various subtypes. We identified four patients harboring HIV variants with a natural polymorphism in the membrane-proximal tyrosine-based signal Y(712)SPL or the Y(802)W(803) diaromatic motif, which are two major determinants of Env intracellular trafficking. Confocal microscopy showed that the intracellular distribution of Env with a mutation in the tyrosine or diaromatic motif differed from that of Env with no mutation in these motifs. Surprisingly, the gp41 CTs of the primary viruses also had differential effects on the intracellular distribution of Env, independently of mutations in the tyrosine or diaromatic motifs, suggesting the involvement of additional determinants. Furthermore, analyses of virus replication kinetics indicated that the effects of mutations in the tyrosine or diaromatic motifs on viral replication depended on the gp41 CT context. These effects were at least partly due to differences in the efficiency of Env incorporation into virions. Thus, polymorphisms in primary HIV-1 gp41 CTs at the quasispecies or subtype level can influence the intracellular distribution of Env, its incorporation into virions, and viral replication capacity.

MeSH Terms
Amino Acid Motifs Amino Acid Sequence Gene Products, env/analysis Gene Products, gag/metabolism HIV Envelope Protein gp41/analysis,genetics,metabolism HIV Infections/virology HIV-1/genetics,physiology,ultrastructure HeLa Cells Humans Kinetics Molecular Sequence Data Polymorphism, Genetic Protein Transport Sequence Alignment Virion/metabolism Virus Assembly/genetics Virus Replication
Chemicals
Gene Products, env Gene Products, gag HIV Envelope Protein gp41
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Lambelé Marie
Université François Rabelais, Tours, France.
Labrosse Béatrice
Roch Emmanuelle
Moreau Alain
Verrier Bernard
Barin Francis
Roingeard Philippe
Mammano Fabrizio
Brand Denys
References (54)
54 references, click to expand
  1. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions.
    Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):343-8 PMID: 10618420
  2. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1.
    J Virol. 2005 Oct;79(19):12132-47 PMID: 16160141
  3. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.
    J Virol. 2000 Apr;74(8):3548-54 PMID: 10729129
  4. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions.
    J Virol. 2000 May;74(10):4891-3 PMID: 10775630
  5. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.
    J Virol. 2000 Sep;74(18):8670-9 PMID: 10954568
  6. Identification of the glycoprotein 41(TM) cytoplasmic tail domains of human immunodeficiency virus type 1 that interact with Pr55Gag particles.
    AIDS Res Hum Retroviruses. 2000 Aug 10;16(12):1141-7 PMID: 10954889
  7. Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity.
    J Virol. 2000 Dec;74(24):11717-23 PMID: 11090171
  8. Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay.
    J Virol. 2001 Jan;75(1):251-9 PMID: 11119595
  9. The simian immunodeficiency virus envelope glycoprotein contains multiple signals that regulate its cell surface expression and endocytosis.
    Traffic. 2000 Aug;1(8):661-74 PMID: 11208154
  10. The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter].
    J Virol. 2001 Mar;75(6):2982-92 PMID: 11222723
  11. Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.
    J Virol. 2001 Jun;75(11):5263-76 PMID: 11333908
  12. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    J Virol. 2001 Oct;75(20):9925-38 PMID: 11559825
  13. Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.
    J Virol. 2002 Apr;76(7):3338-49 PMID: 11884559
  14. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
    J Hum Virol. 2001 Sep-Oct;4(5):249-59 PMID: 11907382
  15. Human macrophages accumulate HIV-1 particles in MHC II compartments.
    Traffic. 2002 Oct;3(10):718-29 PMID: 12230470
  16. Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation.
    J Virol. 2003 Mar;77(6):3634-46 PMID: 12610139
  17. Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.
    J Virol. 2003 Apr;77(7):4081-94 PMID: 12634367
  18. Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivity.
    J Virol. 2003 Jun;77(12):6931-45 PMID: 12768012
  19. Infectious HIV-1 assembles in late endosomes in primary macrophages.
    J Cell Biol. 2003 Aug 4;162(3):443-55 PMID: 12885763
  20. Interclade neutralization and enhancement of human immunodeficiency virus type 1 identified by an assay using HeLa cells expressing both CD4 receptor and CXCR4/CCR5 coreceptors.
    J Infect Dis. 2004 Jan 15;189(2):322-7 PMID: 14722898
  21. The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.
    J Virol. 2004 Feb;78(3):1069-79 PMID: 14722262
  22. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.
    J Virol. 2004 Feb;78(3):1552-63 PMID: 14722309
  23. Short communication: retrospective study to time the introduction of HIV type 1 non-B subtypes in Lyon, France, using env genes obtained from primary infection samples.
    AIDS Res Hum Retroviruses. 2004 Jul;20(7):687-91 PMID: 15307910
  24. Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope.
    J Virol. 2004 Nov;78(22):12625-37 PMID: 15507649
  25. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.
    Science. 1987 Dec 18;238(4834):1704-7 PMID: 3500514
  26. Genetic recombination of human immunodeficiency virus.
    J Virol. 1989 Mar;63(3):1455-9 PMID: 2915387
  27. Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity.
    AIDS Res Hum Retroviruses. 1989 Aug;5(4):441-9 PMID: 2788444
  28. The most highly amphiphilic alpha-helices include two amino acid segments in human immunodeficiency virus glycoprotein 41.
    Biopolymers. 1990 Jan;29(1):171-7 PMID: 2328285
  29. Retrovirus envelope glycoproteins.
    Curr Top Microbiol Immunol. 1990;157:187-253 PMID: 2203609
  30. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.
    J Virol. 1992 Jun;66(6):3306-15 PMID: 1583717
  31. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity.
    J Virol. 1992 Nov;66(11):6616-25 PMID: 1357190
  32. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions.
    J Virol. 1993 Jan;67(1):213-21 PMID: 8416370
  33. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
    J Virol. 1994 Mar;68(3):1689-96 PMID: 8107229
  34. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells.
    J Virol. 1994 Aug;68(8):4857-61 PMID: 8035484
  35. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.
    J Virol. 1995 Jan;69(1):101-9 PMID: 7527081
  36. Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera.
    J Virol. 1995 Jan;69(1):39-48 PMID: 7983734
  37. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
    Nucleic Acids Res. 1994 Nov 11;22(22):4673-80 PMID: 7984417
  38. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.
    J Virol. 1995 Mar;69(3):1984-9 PMID: 7853546
  39. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.
    J Virol. 1995 Jun;69(6):3949-54 PMID: 7745752
  40. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC.
    J Immunol. 1995 Jul 1;155(1):473-88 PMID: 7602119
  41. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
    Science. 1996 May 10;272(5263):872-7 PMID: 8629022
  42. Identification of a major co-receptor for primary isolates of HIV-1.
    Nature. 1996 Jun 20;381(6584):661-6 PMID: 8649511
  43. Direct interaction between the envelope and matrix proteins of HIV-1.
    EMBO J. 1996 Nov 1;15(21):5783-8 PMID: 8918455
  44. The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells.
    EMBO J. 1997 Feb 17;16(4):695-705 PMID: 9049299
  45. A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers.
    Biochemistry. 1997 Apr 29;36(17):5157-69 PMID: 9136877
  46. Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family.
    Virology. 1997 Nov 24;238(2):305-15 PMID: 9400603
  47. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors.
    J Biol Chem. 1998 Jan 2;273(1):404-9 PMID: 9417096
  48. A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor.
    J Biol Chem. 1998 Jun 19;273(25):15773-8 PMID: 9624176
  49. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.
    Science. 1998 Jun 19;280(5371):1884-8 PMID: 9632381
  50. HIV-1 gag proteins: diverse functions in the virus life cycle.
    Virology. 1998 Nov 10;251(1):1-15 PMID: 9813197
  51. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins.
    J Virol. 1999 Feb;73(2):1350-61 PMID: 9882340
  52. Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission.
    J Virol. 1999 Jun;73(6):5010-7 PMID: 10233963
  53. Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection.
    AIDS Res Hum Retroviruses. 1999 Jul 20;15(11):1035-9 PMID: 10445815
  54. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
    J Virol. 2000 Mar;74(6):2855-66 PMID: 10684302
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2007-01-00
Epub
2006-00-18
Pages
125-40
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1797254
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com